Mitotic kinesin inhibitors

Details Mitotic kinesin inhibitors Mitotic kinesin inhibitors

2003-06-12

2008-03-25

Anderson, Rebecca (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S231500, C514S252130, C514S277000, C514S326000, C514S364000, C514S372000, C514S378000, C514S383000, C514S406000, C514S423000, C544S372000, C546S001000, C546S207000, C548S125000, C548S202000, C548S247000, C548S141000, C548S266600, C548S364100, C548S530000

Reexamination Certificate

active

07348440

ABSTRACT:
The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

REFERENCES:
patent: 3644414 (1972-02-01), Helsey et al.
patent: 6057342 (2000-05-01), Fevig et al.
patent: 6440686 (2002-08-01), Sakowicz
patent: 2005/0038074 (2005-02-01), Coleman et al.
patent: 2005/0043357 (2005-02-01), Coleman et al.
patent: 2006/0135594 (2006-06-01), Fraley et al.
patent: 2006/0234984 (2006-10-01), Coleman et al.
patent: 2006/0287302 (2006-12-01), Coleman et al.
patent: 418 845 (1991-03-01), None
patent: WO 93/20099 (1993-10-01), None
patent: WO 98/06694 (1998-02-01), None
patent: WO 03/049527 (2003-06-01), None
patent: WO 03/106417 (2003-12-01), None
patent: WO 2004/037171 (2004-05-01), None
patent: WO 2005/019205 (2005-03-01), None
patent: WO 2005/019206 (2005-03-01), None
Winn et al., AN:1997:568105, RN: 178607-80-2 (1 Page Only).
Fraley et al., “Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP”, Bioorganic&Medicinal Chemistry Letters, 16 (2006), 1775-1779.
Cox et al., “Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP”, Bioorganic&Medicinal Chemistry Letter, 15 (2005), 2041-2045.
Joule et al., “Heterocyclic Chemistry”, 3rdedition, Chapman & Hall, p. 464 (1 Page Only).
N. Moss, et al., Journal of Medicinal Chemistry, vol. 36 (22), pp. 3005-3009 (1993).
C. Sonesson, et al., J. Org. Chem. 1996, vol. 61, p. 4756-4763.
N. Iwasawa, et al., J. Org. Chem. 1998, vol. 63, p. 3164-3165.
N. Iwasawa, et al., J. Org. Chem. 1997, vol. 62, p. 1918-1919.
R. Mison, et al., J. Chem. Research(S), 1989, 126-127.
O. Yebdri, et al., Bulletin De La Societe Chimique de France, 1983, p. 195-201.
A. Ranjon, Bulletin De La Societe Chimique de France, 1971, p. 2068-2072.
M. Bujard, et al., Tetrahedron Letters, vol. 40, 1999, p. 8785-8788.
M. Carpes, et al., Synlett, No. 7, 2000, p. 1037-1039.
A. Boukhari, et al., J. Cryst. Spect. Res., vol. 19, Iss. 3, 1989, p. 603-621.

Affiliated with

Also associated with

Rating

Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3961466